Geographic Shifts in Antibacterial Drug Clinical Trial Enrollment: Implications for Generalizability.

Bart, Stephen M; Farley, John J; Bala, Shukal; Amini, Thushi; Cox, Edward

Bart, Stephen M; Farley, John J; Bala, Shukal; Amini, Thushi; Cox, Edward.

Afiliación

Bart SM; Office of Infectious Diseases, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.
Farley JJ; Office of Infectious Diseases, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.
Bala S; Office of Infectious Diseases, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.
Amini T; Office of Infectious Diseases, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.
Cox E; Office of Infectious Diseases, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.

Clin Infect Dis ; 72(8): 1422-1428, 2021 04 26.

Article en En | MEDLINE | ID: mdl-32161946

Asunto(s)

Antibacterianos; Preparaciones Farmacéuticas; Antibacterianos/uso terapéutico; Europa (Continente); Humanos; América del Norte/epidemiología; Estudios Retrospectivos; Estados Unidos/epidemiología

Palabras clave

Eastern Europe; North America; antibacterial drugs; clinical trials; generalizability

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Antibacterianos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google